Arthronew Gel
NDC Package 61045-0001-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Arthronew (symphytum officinale, capsicum annuum, ledum palustre, colchicum autumnale, rhododendron chrysanthum, ruta graveolens) gel is for temporary relief of minor symptoms of joint pain and inflammation. This formulation utilizes a gel delivery system. Marketed by Purecore Wellness, Inc., this product is identified by NDC 61045-0001.

Identification & Billing

NDC Package Code
61045-0001-1
Package Description
85 g in 1 TUBE
Product Code
61045-0001
11-Digit Billing Format
61045000101

Clinical Specifications

Proprietary Name
Arthronew AM
Non-Proprietary Name
Symphytum Officinale, Capsicum Annuum, Ledum Palustre, Colchicum Autumnale, Rhododendron Chrysanthum, Ruta Graveolens
Substance Name
Capsicum; Colchicum Autumnale Bulb; Comfrey Root; Ledum Palustre Twig; Rhododendron Aureum Leaf; Ruta Graveolens Flowering Top
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
For temporary relief of minor symptoms of joint pain and inflammation. For temporary relief of minor symptoms of joint pain and inflammation.

Regulatory & Marketing

Labeler Name
Purecore Wellness, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-03-2014
End Marketing Date
08-21-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61045-0001-1 identifies a specific commercial package of 85 g in 1 tube of Arthronew AM, a human over the counter drug labeled by Purecore Wellness, Inc.. This gel is formulated for topical use and contains capsicum; colchicum autumnale bulb; comfrey root; ledum palustre twig; rhododendron aureum leaf; ruta graveolens flowering top as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Purecore Wellness, Inc. on November 03, 2014.

How is this Purecore Wellness, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61045000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
61045-0001-1
11-Digit CMS (5-4-2)
61045-0001-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.